Lotus Pharmaceuticals, Inc.
LTUS · OTC
6/30/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $17,454 | $16,152 | $7,814 | $8,892 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $123 |
| Enterprise Value | $17,454 | $16,152 | $7,814 | $9,015 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | $123 | -$4 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$6 | $123 | -$4 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | 0 | 0 | 0 |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | – | -$4 |
| Capital Expenditures | – | – | – | $0 |
| Free Cash Flow | – | – | – | -$4 |